Clinical trial
SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in Patients With Small-Cell Lung Cancer: A Prospective, Randomized, Multicenter Phase III Trial (SHARP Trial)
NCT06457906 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in Patients With Small-Cell Lung Cancer: A Prospective, Randomized, Multicenter Phase III Trial (SHARP Trial)
- Lead sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 1, 2023
- Completion date
- February 28, 2028
- Enrollment
- 340 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain metastases, hippocampal-avoidance, small-cell lung cancer, srs, stereotactic radiotherapy, whole brain radiotherpay